IL1B and myeloid sarcoma: The results of studies on the expression level of IL-1β in the sera and CSF of MS patients are contradictory, and the level of IL-1β was increased or not detected in different studies (Maimone et al., 1991; Peter et al., 1991; Dujmovic et al., 2009).